Everfront Biotech Inc.

Taïwan, Province de Chine

Commandez votre montre hebdomadaire Everfront Biotech Inc.
Quantité totale PI 12
Rang # Quantité totale PI 129 262
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 344 458
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

10 1
0 0
0 0
1
 
Dernier brevet 2024 - Use of phthalide compounds in tr...
Premier brevet 2014 - Use of butylidenephthalide (bdph...
Dernière marque 2024 - CEREBRACA
Première marque 2015 - Cerebraca

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S pharmaceutical preparation in the nature of a biodegradable implant for the medical treatment of ...
2021 Invention Use of phthalide compounds in treatment of meningioma. The present invention relates to the use ...
Invention Combination for the treatment of cancer and application thereof. A combination, comprising a fir...
2018 Invention Uses of butylidenephthalide. A method for decreasing the incidence rate and/or recurrent rate of ...
2017 Invention Use of z-butylidenephthalide in activating autoimmune system. A method for at least one of activa...
Invention Method for delaying the onset of pulmonary fibrosis or treating pulmonary fibrosis. The present i...
2016 Invention Uses of butylidenephthalide. A method for preventing, mitigating and/or inhibiting the growth, m...
Invention Use of butylidenephthalide. Disclosed is the use of an active ingredient in the manufacture of a ...
2015 Invention Method for preparing isobenzofuran-1(3h)-one compound. A method for preparing an isobenzofuran-1(...
P/S Pharmaceutical preparations; medicine.
Invention Stable pharmaceutical composition. (b) n-butylidenephthalide (BP).
2014 Invention Method for treating and/or delaying the degeneration of purkinje cells. A method for treating and...
Invention Use of butylidenephthalide (bdph), method of using the same, and method for preparing pharmaceuti...